Zentalis Pharmaceuticals, Inc.
ZNTL
10 insider filings · Latest: Jun 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Feb 11 2:10 AM | Ingmar BrunsChief Medical Officer | Sale | 335 | $2.39 | $802 | 33,332(D) | View → |
| Feb 6, 2026 | Feb 11 2:10 AM | Ingmar BrunsChief Medical Officer | Sale | 2,962 | $2.43 | $7.2K | 33,667(D) | View → |
| Feb 10, 2026 | Feb 11 2:10 AM | Vincent VultaggioPAO and PFO | Sale | 6,894 | $2.42 | $16.7K | 146,506(D) | View → |
| Feb 9, 2026 | Feb 11 2:10 AM | Vincent VultaggioPAO and PFO | Sale | 3,379 | $2.39 | $8.1K | 153,400(D) | View → |
| Feb 6, 2026 | Feb 11 2:10 AM | Vincent VultaggioPAO and PFO | Sale | 29,951 | $2.43 | $72.8K | 156,779(D) | View → |
| Feb 9, 2026 | Feb 11 2:09 AM | Julia Marie EastlandDirector, CEO & President | Sale | 889 | $2.39 | $2.1K | 79,133(D) | View → |
| Feb 6, 2026 | Feb 11 2:09 AM | Julia Marie EastlandDirector, CEO & President | Sale | 7,866 | $2.43 | $19.1K | 80,022(D) | View → |
| Feb 3, 2026 | Feb 5 1:27 AM | Vincent VultaggioPAO and PFO | Sale | 556 | $2.52 | $1.4K | 186,730(D) | View → |
| Feb 2, 2026 | Feb 5 1:27 AM | Vincent VultaggioPAO and PFO | Sale | 2,540 | $2.55 | $6.5K | 187,286(D) | View → |
| Feb 11, 2025 | Feb 12 1:06 AM | Cam Gallagher | Proposed Sale | 687 | $2.00 | $1.4K | — | View → |
| Feb 3, 2025 | Feb 4 12:14 AM | Mark Lackner | Proposed Sale | 14,368 | $1.71 | $24.6K | — | View → |
| Feb 3, 2025 | Feb 4 12:13 AM | Andrea Paul | Proposed Sale | 13,230 | $1.71 | $22.6K | — | View → |
| Feb 3, 2025 | Feb 4 12:12 AM | Cam Gallagher | Proposed Sale | 28,558 | $1.71 | $48.9K | — | View → |
| Oct 31, 2024 | Nov 1 12:59 AM | Diana Hausman | Proposed Sale | 9,888 | $2.86 | $28.3K | — | View → |
Stock Options & Derivatives
No transactions found.